Clinical Trial: Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915011) titled 'Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment' on Oct. 29.

Brief Summary: The study is being conducted to compare the pharmacokinetics, safety of HSK31858 in subjects with mild, moderate, severe renal impairment and normal renal function.

Study Start Date: May 26

Study Type: INTERVENTIONAL

Condition: Non-cystic Fibrosis Bronchiectasis (NCFBE)

Intervention: DRUG: HSK31858 tablets

oral

Recruitment Status: RECRUITING

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....